Sherwin-Williams (SHW) delivered mixed results in FY2026 on revenue of $105.6B versus the $101.8B estimate (+19.8% YoY) and EPS of $0.72. Below is the full Sherwin-Williams earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$105.6B (vs $101.8B est · +3.7% surprise · +19.8% YoY)
EPS
$0.72 (vs $0.75 est · -4.0% surprise · -3.4% YoY)
Share price
$354.76 (+2.8%)
Market cap
$750.0B
What you'll find
Next Sherwin-Williams (SHW) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Sherwin-Williams reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Sherwin-Williams (SHW)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Sherwin-Williams's next earnings date?
Sherwin-Williams's (SHW) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Sherwin-Williams (SHW) beat or miss earnings?
In FY2026, Sherwin-Williams (SHW) posted mixed results — revenue of $105.6B versus the $101.8B estimate (+3.7% surprise) and EPS of $0.72 versus $0.75 expected (-4.0% surprise). Magnisto decodes every Sherwin-Williams (SHW) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Sherwin-Williams (SHW) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Sherwin-Williams (SHW), anchored to the current $354.76 share price, so you can weigh the bull, base and bear cases for Sherwin-Williams side by side.
Is Sherwin-Williams (SHW) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Sherwin-Williams fits your own thesis and risk profile. This is research, not investment advice.